Status:
COMPLETED
Low-Cost Molecular Cervical Cancer Screening Study
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
DNA Probes
E6 Protein
Eligibility:
FEMALE
25-65 years
Brief Summary
Background: \- Low-cost molecular human papillomavirus (HPV) testing may offer a more robust alternative to Pap smears and visual inspection for cervical cancer screening of underserved women. Two lo...
Detailed Description
Low-cost, molecular human papillomavirus (HPV) testing may offer a more robust alternative to Pap smears and visual inspection with acetic acid (VIA) for cervical cancer screening of underserved women...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- have not been previously diagnosed with cervical cancer
- have a cervix
- are not pregnant
- are physically able to undergo routine cervical cancer screening 5) are able to provide informed consent
- We will not exclude women if they have had previous cervical cancer screening because we assume that even if a few women have been screened for cervical cancer, the quality of cytology screening was very poor.
- EXCLUSION CRITERIA:
- 1\) are not married AND report never having had sexual intercourse 2) have had a total hysterectomy
- 3\) have a history of cervical cancer
- 4\) are physically or mentally unable to undergo routine cervical cancer screening or unable to provide informed consent.
- 5\) are pregnant or have been pregnant in the last month
- Women who are currently menstruating at the time of enrollment will be deferred from participating, and will become eligible to participate 7-14 days after menstruation has ended. The menstruating women will be advised to return for the screening 7 to 14 days after their menstrual period has concluded.
Exclusion
Key Trial Info
Start Date :
October 11 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2010
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT01231945
Start Date
October 11 2010
End Date
December 20 2010
Last Update
July 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
PATH
Seattle, Washington, United States
2
CICAMS
Beijing, Beijing Municipality, China